Research Into Visual Endpoints and RB Health Outcomes After Treatment (RIVERBOAT)

This is a cross-sectional, non-therapeutic study in a cohort of retinoblastoma patients. The study will estimate the prevalence of specific late effects and SMN, assess for predictors of these late effects and SMN, and identify factors predictive of these late effects and SMN, and identify factors predictive of decreased HRQoL.